These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19732499)

  • 1. Impact of surface tension in pharmaceutical sciences.
    Fathi Azarbayjani A; Jouyban A; Chan SY
    J Pharm Pharm Sci; 2009; 12(2):218-28. PubMed ID: 19732499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid dispersions: a review.
    Dhirendra K; Lewis S; Udupa N; Atin K
    Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent patents and trends in orally disintegrating tablets.
    AlHusban FA; El-Shaer AM; Jones RJ; Mohammed AR
    Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):178-97. PubMed ID: 20626334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for the pharmaceutical technical development of protein coformulations.
    Mueller C; Altenburger U; Mohl S
    J Pharm Pharmacol; 2018 May; 70(5):666-674. PubMed ID: 28470967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century.
    Tiwari RV; Patil H; Repka MA
    Expert Opin Drug Deliv; 2016; 13(3):451-64. PubMed ID: 26886062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
    Stanković M; Frijlink HW; Hinrichs WL
    Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
    Cole KP; Johnson MD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supercritical fluid particle design for poorly water-soluble drugs (review).
    Sun Y
    Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
    Shanbhag A; Rabel S; Nauka E; Casadevall G; Shivanand P; Eichenbaum G; Mansky P
    Int J Pharm; 2008 Mar; 351(1-2):209-18. PubMed ID: 18054181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
    Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
    Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melt extrusion with poorly soluble drugs - An integrated review.
    Repka MA; Bandari S; Kallakunta VR; Vo AQ; McFall H; Pimparade MB; Bhagurkar AM
    Int J Pharm; 2018 Jan; 535(1-2):68-85. PubMed ID: 29102700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y; Porter W; Merdan T; Li LC
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
    Newman A; Nagapudi K; Wenslow R
    Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.